USFDA inspects Alembic Pharmaceuticals' Oncology Injectable Formulation Facility at Panelav

The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' Oncology Injectable Formulation Facility located at Panelav from 4th October, 2022 to 14th October, 2022.

The USFDA issued a Form 483 with 4 procedural observations.

None of the observations are related to data integrity and management believes that they are addressable.

The Company is preparing the response to the observations, which will be submitted to the USFDA within stipulated period.

The Company is committed to maintain the highest quality standards and compliance at all times.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 569.50 as compared to the previous close of Rs. 571.45. The total number of shares traded during the day was 2576 in over 259 trades.

The stock hit an intraday high of Rs. 575.05 and intraday low of 566.85. The net turnover during the day was Rs. 1467943.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 Inspection USFDA OncologyInjectableFormulationFacility Panelav 4Observations Form483